Alpha Diagnostic International, Inc. Anti-Human Neuroligin 2 (NLGN2) Control/blocking peptide NLGN21-P

Anti-Human Neuroligin 2 (NLGN2) Control/blocking peptide General Information Neuroligins are Type I membrane proteins enriched in synaptic plasma membranes and clustered in synaptic clefts and postsynaptic densities. They have been characterized as neuronal cell surface proteins and are thought to be involved in cell-cell-interact SugApplications Control or blocking peptides are recommended for ELISA plate coating for direct ELISA testing of antibodies or competitive ELISA, and antibody blocking or neutralization. SpeciesReactivity Human Form Antigen/blocking Peptide Antigen 18- aa peptide of Human NLGN2 (Protein accession # Q8NFZ4 ; ref. 1); designated as NLGN21-P control/blocking peptide conjugated to KLH; epitope location ~~C-terminus, cytoplasmic SpCrossreactivity Human NLGN21-P peptide sequence is 100% conserved in both mouse and rat NLGN2 protein. Antibody cross-reactivity in various species is not known. For research use only, not for diagnostic or therapeutic use.